Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −18,500−100.0% | Sold out | Holders |
| Q3 2022 | 18,500 | $78.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 18,500 | $52.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 18,500 | $106.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 18,500 | $169.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 18,500 | $198.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 18,500 | $287.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 18,500 | $300.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.